[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:mycosis-fungoides":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":189,"states":190},"Mycosis Fungoides",29,23,[8,16,23,29,35,41,47,54,60,67,73,79,85,91,97,103,109,115,121,127,133,139,145,151,158,163,169,175,182],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05838599","Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides",[12],"Early Phase 1","RECRUITING","2026-08-26T02:18:09.641312Z","2026-05-13T02:55:06.380027Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04930653","Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma",[20],"Phase 2","2026-08-03T03:09:55.663340Z","2026-05-05T02:43:29.525932Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05680558","Photopheresis in Early-stage Mycosis Fungoides",[20],"2026-08-26T02:17:04.346841Z","2026-05-05T02:43:29.053003Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT03398161","Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides",[20],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:27.747357Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05956041","Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed\u002FRefractory Cutaneous T-cell Lymphomas",[20],"2026-08-26T02:18:25.327036Z","2026-05-05T02:43:27.623186Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT05357794","Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides",[20],"2026-08-26T02:17:47.813245Z","2026-05-05T02:43:27.245802Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT05296304","A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides",[51],"Phase 1","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:26.900130Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06508463","Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma",[51],"2026-08-26T02:18:07.037408Z","2026-07-05T05:32:16.756962Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT03011814","Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma",[64],"Phase 1\u002FPhase 2","2026-08-26T02:19:13.549512Z","2026-06-17T02:29:30.057758Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT04256018","Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome",[20],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:28.661336Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT03587844","Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients",[20],"2026-08-26T02:15:47.754948Z","2026-05-05T02:43:28.021905Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT06580002","Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial",[20],"2026-08-26T02:15:04.877798Z","2026-07-19T19:36:05.038415Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT07192471","A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma",[51],"2026-08-26T02:17:59.904383Z","2026-07-05T05:32:16.661363Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT03017820","A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma",[51],"2026-08-26T02:19:05.360997Z","2026-06-16T05:54:07.906191Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT05079282","Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma",[51],"2026-08-26T02:17:12.307088Z","2026-05-05T02:43:29.642831Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT05996185","Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma",[20],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:28.341848Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT05967416","Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma",[51],"2026-08-26T02:15:43.339060Z","2026-05-05T02:43:27.815843Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT03125642","Auto Stem Cell Transplant for Lymphoma Patients",[20],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:26.753431Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT07003100","A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab",[],"2026-08-26T02:15:58.452248Z","2026-05-13T02:55:06.604967Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT06207812","Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis",[],"2026-08-26T02:17:41.695983Z","2026-05-13T02:55:06.425302Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT02702310","Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides",[],"2026-08-03T03:19:09.261668Z","2026-05-13T02:55:06.099443Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT02848274","ID Of Prognostic Factors In Mycosis Fungoides\u002FSezary Syndrome",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.101874Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT05978141","A Registry for People With T-cell Lymphoma",[],"2026-08-26T02:16:20.336282Z","2026-05-13T02:55:06.403613Z",{"nct_id":152,"title":153,"phases":154,"status":155,"updated_at":156,"content_modified":157},"NCT07529405","A Study of VG712 in Patients With Mycosis Fungoides",[20],"NOT_YET_RECRUITING","2026-08-26T02:17:51.502023Z","2026-05-05T02:43:27.307728Z",{"nct_id":159,"title":160,"phases":161,"status":155,"updated_at":143,"content_modified":162},"NCT05728879","Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution",[12],"2026-05-05T02:35:31.914971Z",{"nct_id":164,"title":165,"phases":166,"status":155,"updated_at":167,"content_modified":168},"NCT07714187","A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides",[51],"2026-08-26T02:15:21.365312Z","2026-07-24T01:27:14.909226Z",{"nct_id":170,"title":171,"phases":172,"status":155,"updated_at":173,"content_modified":174},"NCT07682792","Golidocitinib in Patients With Mycosis Fungoides\u002FSézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia",[20],"2026-08-26T02:19:16.454910Z","2026-07-19T19:36:05.150066Z",{"nct_id":176,"title":177,"phases":178,"status":179,"updated_at":180,"content_modified":181},"NCT06665490","Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:46.653867Z","2026-06-16T05:54:07.764880Z",{"nct_id":183,"title":184,"phases":185,"status":186,"updated_at":187,"content_modified":188},"NCT03690011","Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells",[51],"ACTIVE_NOT_RECRUITING","2026-08-03T03:05:09.265674Z","2026-05-05T02:43:27.128098Z",[],[191,195,198,202,206,209,213,216,220,223,226,229,233,236],{"state":192,"count":193,"slug":194},"California",11,"california",{"state":196,"count":193,"slug":197},"Texas","texas",{"state":199,"count":200,"slug":201},"New York",8,"new-york",{"state":203,"count":204,"slug":205},"New Jersey",6,"new-jersey",{"state":207,"count":204,"slug":208},"Pennsylvania","pennsylvania",{"state":210,"count":211,"slug":212},"Georgia",5,"georgia",{"state":214,"count":211,"slug":215},"Missouri","missouri",{"state":217,"count":218,"slug":219},"Florida",4,"florida",{"state":221,"count":218,"slug":222},"Illinois","illinois",{"state":224,"count":218,"slug":225},"Massachusetts","massachusetts",{"state":227,"count":218,"slug":228},"Minnesota","minnesota",{"state":230,"count":231,"slug":232},"Arizona",3,"arizona",{"state":234,"count":231,"slug":235},"Connecticut","connecticut",{"state":237,"count":231,"slug":238},"Ohio","ohio"]